ID VTNC_RABIT Reviewed; 475 AA. AC P22458; DT 01-AUG-1991, integrated into UniProtKB/Swiss-Prot. DT 01-AUG-1991, sequence version 1. DT 24-JAN-2024, entry version 146. DE RecName: Full=Vitronectin; DE Short=VN; DE AltName: Full=Glycoprotein 66; DE AltName: Full=S-protein; DE AltName: Full=Serum-spreading factor; DE Flags: Precursor; GN Name=VTN; OS Oryctolagus cuniculus (Rabbit). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae; Oryctolagus. OX NCBI_TaxID=9986; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA], AND PARTIAL PROTEIN SEQUENCE. RX PubMed=1701177; DOI=10.1016/s0021-9258(17)45350-6; RA Sato R., Komine Y., Imanaka T., Takano T.; RT "Monoclonal antibody EMR1a/212D recognizing site of deposition of RT extracellular lipid in atherosclerosis. Isolation and characterization of a RT cDNA clone for the antigen."; RL J. Biol. Chem. 265:21232-21236(1990). RN [2] RP PROTEIN SEQUENCE OF 20-44, AND GLYCOSYLATION. RX PubMed=1372829; DOI=10.1016/0167-4838(92)90417-c; RA Nakashima N., Miyazaki K., Ishikawa M., Yatohgo T., Ogawa H., Uchibori H., RA Matsumoto I., Seno N., Hayashi M.; RT "Vitronectin diversity in evolution but uniformity in ligand binding and RT size of the core polypeptide."; RL Biochim. Biophys. Acta 1120:1-10(1992). CC -!- FUNCTION: Vitronectin is a cell adhesion and spreading factor found in CC serum and tissues. Vitronectin interact with glycosaminoglycans and CC proteoglycans. Is recognized by certain members of the integrin family CC and serves as a cell-to-substrate adhesion molecule. Inhibitor of the CC membrane-damaging effect of the terminal cytolytic complement pathway. CC -!- SUBUNIT: Interacts with SERPINE1/PAI1 and C1QBP (By similarity). CC Monomer. {ECO:0000250}. CC -!- SUBCELLULAR LOCATION: Secreted, extracellular space. CC -!- TISSUE SPECIFICITY: Plasma. CC -!- DOMAIN: The SMB domain mediates interaction with SERPINE1/PAI1. CC {ECO:0000250}. CC -!- PTM: Sulfated on tyrosine residues. {ECO:0000250|UniProtKB:P04004}. CC -!- PTM: N- and O-glycosylated. {ECO:0000269|PubMed:1372829}. CC -!- PTM: It has been suggested that the active SMB domain may be permitted CC considerable disulfide bond heterogeneity or variability, thus two CC alternate disulfide patterns based on 3D structures are described with CC 1 disulfide bond conserved in both. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M55442; AAA31258.1; -; mRNA. DR PIR; A38340; A38340. DR RefSeq; NP_001075761.1; NM_001082292.1. DR AlphaFoldDB; P22458; -. DR SMR; P22458; -. DR CORUM; P22458; -. DR STRING; 9986.ENSOCUP00000024132; -. DR GlyCosmos; P22458; 3 sites, No reported glycans. DR iPTMnet; P22458; -. DR PaxDb; 9986-ENSOCUP00000024132; -. DR GeneID; 100009128; -. DR KEGG; ocu:100009128; -. DR CTD; 7448; -. DR eggNOG; KOG1565; Eukaryota. DR InParanoid; P22458; -. DR OrthoDB; 5310951at2759; -. DR Proteomes; UP000001811; Unplaced. DR GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell. DR GO; GO:0008201; F:heparin binding; IEA:UniProtKB-KW. DR GO; GO:0030247; F:polysaccharide binding; IEA:InterPro. DR GO; GO:0005044; F:scavenger receptor activity; IEA:InterPro. DR GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW. DR GO; GO:0006955; P:immune response; IEA:InterPro. DR CDD; cd00094; HX; 1. DR Gene3D; 4.10.410.20; -; 1. DR Gene3D; 2.110.10.10; Hemopexin-like domain; 2. DR InterPro; IPR000585; Hemopexin-like_dom. DR InterPro; IPR036375; Hemopexin-like_dom_sf. DR InterPro; IPR018487; Hemopexin-like_repeat. DR InterPro; IPR018486; Hemopexin_CS. DR InterPro; IPR020436; SMB_chordata. DR InterPro; IPR036024; Somatomedin_B-like_dom_sf. DR InterPro; IPR001212; Somatomedin_B_dom. DR PANTHER; PTHR22917; HEMOPEXIN DOMAIN-CONTAINING PROTEIN; 1. DR PANTHER; PTHR22917:SF3; VITRONECTIN; 1. DR Pfam; PF00045; Hemopexin; 4. DR Pfam; PF01033; Somatomedin_B; 1. DR PRINTS; PR00022; SOMATOMEDINB. DR SMART; SM00120; HX; 4. DR SMART; SM00201; SO; 1. DR SUPFAM; SSF50923; Hemopexin-like domain; 1. DR SUPFAM; SSF90188; Somatomedin B domain; 1. DR PROSITE; PS00024; HEMOPEXIN; 2. DR PROSITE; PS51642; HEMOPEXIN_2; 4. DR PROSITE; PS00524; SMB_1; 1. DR PROSITE; PS50958; SMB_2; 1. PE 1: Evidence at protein level; KW Cell adhesion; Direct protein sequencing; Disulfide bond; Glycoprotein; KW Heparin-binding; Phosphoprotein; Reference proteome; Repeat; Secreted; KW Signal; Sulfation. FT SIGNAL 1..19 FT /evidence="ECO:0000269|PubMed:1372829" FT CHAIN 20..475 FT /note="Vitronectin" FT /id="PRO_0000036400" FT DOMAIN 20..63 FT /note="SMB" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00350" FT REPEAT 158..202 FT /note="Hemopexin 1" FT REPEAT 203..250 FT /note="Hemopexin 2" FT REPEAT 251..305 FT /note="Hemopexin 3" FT REPEAT 419..469 FT /note="Hemopexin 4" FT REGION 87..123 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 359..391 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 366..392 FT /note="Glycosaminoglycan binding region" FT MOTIF 64..66 FT /note="Cell attachment site" FT COMPBIAS 87..108 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 366..388 FT /note="Basic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOD_RES 69 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:P04004" FT MOD_RES 75 FT /note="Sulfotyrosine" FT /evidence="ECO:0000255" FT MOD_RES 78 FT /note="Sulfotyrosine" FT /evidence="ECO:0000255" FT MOD_RES 80 FT /note="Sulfotyrosine" FT /evidence="ECO:0000255" FT MOD_RES 279 FT /note="Sulfotyrosine" FT /evidence="ECO:0000255" FT MOD_RES 282 FT /note="Sulfotyrosine" FT /evidence="ECO:0000255" FT MOD_RES 312 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P04004" FT MOD_RES 394 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P04004" FT CARBOHYD 87 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000305|PubMed:1372829" FT CARBOHYD 169 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000305|PubMed:1372829" FT CARBOHYD 242 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000305|PubMed:1372829" FT DISULFID 24..40 FT /note="Alternate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00350" FT DISULFID 24..28 FT /note="Alternate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00350" FT DISULFID 28..58 FT /note="Alternate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00350" FT DISULFID 38..51 FT /note="Alternate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00350" FT DISULFID 38..40 FT /note="Alternate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00350" FT DISULFID 44..50 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00350" FT DISULFID 51..58 FT /note="Alternate" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00350" FT CONFLICT 26 FT /note="D -> G (in Ref. 2; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 34..35 FT /note="AN -> SD (in Ref. 2; AA sequence)" FT /evidence="ECO:0000305" FT CONFLICT 44 FT /note="C -> P (in Ref. 2; AA sequence)" FT /evidence="ECO:0000305" SQ SEQUENCE 475 AA; 53943 MW; D5D1F31B8C2FA12D CRC64; MAPLRPIFTL ALLLWVVLAD QESCKDRCTE GFNANRKCQC DELCSYYQSC CADYAAECKP QVTRGDVFTM PEDEYGPYDY IEQTKDNASV HAQPESPTVG QEPTLSPDLQ TEGGAEPTHE VPLEPEMETL RPEGEDLQAG TTELGTSASP AEEELCSGKP FDAFTDLKNG SLFAFRGQYC YELDETAVRP GYPKLIQDVW GIEGPIDAAF TRINCQGKTY LFKGSQYWRF EDGILDPDYP RNISEGFSGI PDNVDAAFAL PAHSYSGRER VYFFKGDKYW EYQFQQQPSQ EECEGSSLSA VFEHFAMLHR DSWEDIFKLL FWGRPSGGAR QPQFISRDWH GVPGKVDAAM AGRIYISGLT PSPSAKKQKS RRRSRKRYRS RYGRGRSQNS RRLSRSISRL WFSSEEVSLG PYNYEDYETS WLKPATSEPI QSVYFFSGDK YYRVNLRTQR VDTVNPPYPR SIAQYWLGCP APGGQ //